Santa Cruz Biotechnologyscbtis A Biotechnology Company Based In Dallastexasfounded In 1991The Company Focuses On Supplying Products For Biomedical Research And Operates In The Biotechnologychemicalsand Manufacturing Sectorswith Around 180 Employeesscbt Generates An Estimated $22 Million In Annual Revenue Scbt Specializes In Developing Research Toolsincluding Monoclonal Antibodiesbiochemicalslabwareand Crispr Gene Editing Productsit Is Recognized As A Global Leader In Antibody Productionconsistently Ranking Among The Top Suppliers In Industry Surveysthe Company Provides A Wide Range Of Productsincluding Animal Derived Antibodiesreagents For Laboratory Useand Equipment For Research Workflowsscbt S Products Are Widely Cited In Over 360 000 Scientific Publicationsserving A Diverse Customer Base In Academicpharmaceuticaland Biotech Research
